Coagulation Analysers Market

Global Coagulation Analysers Market: Overview

The global coagulation analysers market is treading along a lucrative trajectory in recent times. The apparent advancements in healthcare technologies has played a vital role in market growth. The unpredictability of the incidence of blood coagulation in humans necessitates the presence of proper coagulation analysis devices across healthcare centers. This factor, coupled with the increased budgets of the healthcare sector, has aided market growth. The geriatric population is prone of suffering from blood-related diseases. Majority of these diseases are related to extreme levels of coagulation in the body. The medical fraternity is making valued efforts to improve healthcare facilities for the elderly.

Patients suffering from blood disorders require constant monitoring and scrutiny of their health. This factor has paved way for the development of nimble and portable coagulation analysers and monitoring devices. Moreover, the incidence of blood clotting amongst children and young adults has witnessed a sharp increase in recent times. This factor has also played an integral role in the growth of the global coagulation analysers market.

A review on the global coagulation analysers market by Transparency Market Research (TMR) unravels a multitude of factors pertaining to market growth. The global coagulation analysers market can be segmented on the basis of the following parameters: product type, end-user, and region. The demand for coagulation analysers across diagnostic centers is slated to ramp up in the following years.

Global Coagulation Analysers Market: Notable Developments

The need for continual testing of patients suffering from blood disorders has inspired the development of various cutting-edge technologies.

• Beckman Coulter, Inc. introduced the Grifolis Q series of coagulation analysers that are capable of performing quick coagulation analysis, in approximately 30 minutes. The ready-to-use reagents used in the new device have helped the company track down on a new milestone within clotting analysis. Other vendors in the market are expected to draw inspiration from the innovative approach followed by Beckman Coulter.
• The need for coagulation analysers across small hospitals and day care centers has led market vendors to introduce less expensive lines of products. This trend is expected to magnify as financial incentive towards healthcare manufacturing increase. The use of coagulation analysers in laboratories has also fetched a fresh consumer base for the market players.

Some of the leading players in the global coagulation analysers market are:

• Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
• Sysmex Corporation
• Siemens Healthcare (AG),
• Thermo Fisher Scientific Inc.

Global Coagulation Analysers Market: Growth Drivers

• Rising Incidence of Cardiovascular Diseases

The presence of a well-performing healthcare industry is a boon for vendors operating in the global coagulation analysers market. The rising incidence of cardiovascular diseases has convinced healthcare providers about the need for cutting-edge analysis technologies. Hence, the adoption rate of coagulation analysers across healthcare centers and hospitals has increased by leaps and bounds. The changing healthcare requirements of the geriatric population has also driven demand within the global coagulation analysers market.

• Advancements in Biological Labs

The need for vitro diagnostic clinical haemostasis has also generated demand within the global market. Biological laboratories actively use of coagulation analysers to carry out a range of experiments and tests. Moreover, physicians are constantly on the lookout for improved coagulation analysers to effectuate better diagnosis and treatment. Anticoagulant therapy monitoring has gained traction across the global healthcare setup. The aforementioned factors have played a stellar role in driving adoption of coagulation analysers.